Future of HIV-1 Therapeutics
-15%
portes grátis
Future of HIV-1 Therapeutics
Resistance Is Futile?
Goodsell, David S.; Richman, Douglas D.; Torbett, Bruce E.
Springer International Publishing AG
10/2016
254
Mole
Inglês
9783319374505
15 a 20 dias
4044
Descrição não disponível.
HIV Therapy - Looking Towards the Future.- Computational challenges of structure-based approaches applied to HIV.- Nucleocapsid Protein: A Desirable Target For Future Therapies Against HIV-1.- HIV-1 integrase multimerization as a therapeutic target.- Targeting HIV transcription: The quest for a functional cure.- Targeting the HIV RNA Genome: High-Hanging Fruit Only Needs a Longer Ladder.- HIV-1 Gag: An Emerging Target for Antiretroviral Therapy.- The Triple Threat of HIV-1 Protease Inhibitors.- Illustrations of the HIV Life Cycle.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Fragment-based drug design;HIV Gag protein;HIV capsid;HIV integrase protein;HIV matrix;HIV nucleocapsid protein;HIV protease;HIV reverse transcriptase protein;HIV stem-loop;HIV transcription;HIV-1 antiretroviral treatment;HIV-1 drug resistance;HIV-1 illustrations;HIV-1 latency;High-throughput virtual screening;Human immunodeficiency virus;LEDGF/p75 protein;Rev protein;Structure-based drug design;Tat/TAR/P-TEFb complex;antibacterial drug resistance
HIV Therapy - Looking Towards the Future.- Computational challenges of structure-based approaches applied to HIV.- Nucleocapsid Protein: A Desirable Target For Future Therapies Against HIV-1.- HIV-1 integrase multimerization as a therapeutic target.- Targeting HIV transcription: The quest for a functional cure.- Targeting the HIV RNA Genome: High-Hanging Fruit Only Needs a Longer Ladder.- HIV-1 Gag: An Emerging Target for Antiretroviral Therapy.- The Triple Threat of HIV-1 Protease Inhibitors.- Illustrations of the HIV Life Cycle.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Fragment-based drug design;HIV Gag protein;HIV capsid;HIV integrase protein;HIV matrix;HIV nucleocapsid protein;HIV protease;HIV reverse transcriptase protein;HIV stem-loop;HIV transcription;HIV-1 antiretroviral treatment;HIV-1 drug resistance;HIV-1 illustrations;HIV-1 latency;High-throughput virtual screening;Human immunodeficiency virus;LEDGF/p75 protein;Rev protein;Structure-based drug design;Tat/TAR/P-TEFb complex;antibacterial drug resistance
